Comparison

NCR3 Antibody, HRP conjugated

Item no. CSB-PA015551LB01HU-50ug
Manufacturer Cusabio
Amount 50 ug
Quantity options 100 ug 50 ug
Category
Type Antibody Polyclonal
Format Liquid
Applications ELISA
Specific against Human (Homo sapiens)
Host Rabbit
Isotype IgG
Conjugate/Tag HRP
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias 1C7 antibody; Activating natural killer receptor p30 antibody; Activating NK A1 receptor antibody; CD337 antibody; CD337 antigen antibody; LY117 antibody; Lymphocyte antigen 117 antibody; MALS antibody; Natural cytotoxicity triggering receptor 3 antibody; Natural killer cell p30 related protein antibody; Natural killer cell p30-related protein antibody; Ncr3 antibody; NCTR3_HUMAN antibody; NK-p30 antibody; NKp30 antibody
Similar products NCR3, Natural cytotoxicity triggering receptor 3 (Activating natural killer receptor p30) (Natural killer cell p30-related protein) (NK-p30) (NKp30) (CD antigen CD337), 1C7 LY117
Available
Manufacturer - Type
Polyclonal Antibody
Manufacturer - Targets
NCR3
Storage Conditions
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Manufacturer - Alias
1C7 antibody; Activating natural killer receptor p30 antibody; Activating NK A1 receptor antibody; CD337 antibody; CD337 antigen antibody; LY117 antibody; Lymphocyte antigen 117 antibody; MALS antibody; Natural cytotoxicity triggering receptor 3 antibody; Natural killer cell p30 related protein antibody; Natural killer cell p30-related protein antibody; Ncr3 antibody; NCTR3_HUMAN antibody; NK-p30 antibody; NKp30 antibody
Immunogen Species
Human
Immunogen
Recombinant Human Natural cytotoxicity triggering receptor 3 protein (19-135AA)
Background
Cell membrane receptor of natural killer/NK cells that is activated by binding of extracellular ligands including BAG6 and NCR3LG1. Stimulates NK cells cytotoxicity toward neighboring cells producing these ligands. It controls, for instance, NK cells cytotoxicity against tumor cells. Engagement of NCR3 by BAG6 also promotes myeloid dendritic cells (DC) maturation, both through killing DCs that did not acquire a mature phenotype, and inducing the release by NK cells of TNFA and IFNG which promote DC maturation.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Purification Method
>95%, Protein G purified
General Research Areas
Immunology
Initial Research Areas
Immunology
Antigen Species
Human
Antigen
Recombinant Human Natural cytotoxicity triggering receptor 3 protein (19-135AA)
Clonality
Polyclonal

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close